Willkie Farr & Gallagher LLP·Jan 1, 2026 Turnarounds & Workouts Selects John Longmire as 2015 ...
Greg Schiffman - Director | StableX Technologies (SBLX) Executive ...
Dendreon Corporation - PSZJ
Cambridgenetwork·Oct 8, 2024 Why copying the best might be your worst strategy
Pharmaceutical Technology·Dec 22, 2023 2023 in review: Cancer vaccines dose up on advances with tailored ...
Portage Point Partners·Jun 26, 2023 Steve Bremer | Integrated Team of Experts | Portage Point Partners
Could Moderna/Merck Cancer Vaccine Succeed Where Others ...
Inknowvation·Jan 24, 2023 Dendreon Corporation | www.inknowvation.com
Paul, Weiss Adds Distinguished Restructuring Partner
Fiercepharma·Jun 17, 2021 Long-suffering Dendreon finds new avatar as contract manufacturer …
Rightsforinvestors·Mar 24, 2020 Brian Andrew Bond Barred from Securities Industry – Goodman & Nekvasil P.A, May Recover Investor Losses
Mcdermottlaw·Sep 27, 2019 Felicia Gerber Perlman | People - McDermott
Mcdermottlaw·Sep 27, 2019 Felicia Gerber Perlman | People - McDermott Will & Schulte
Is the Sipuleucel-T Saga Poised for a New Chapter?
Dendreon Corporation - Stretto
Translating Regenerative Medicine Science into Clinical Practice
Dendreon Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
www.statnews.com·Jul 8, 2016 In Juno patient deaths, echoes seen of earlier failed company
The New York Times·Feb 22, 2016 Dendreon Corporation - The New York Times
Dendreon Takes $400M Valeant Bid, Nixes Ch. 11 Auction - Law360
